Goldman Sachs’s Lucira Health, Inc. Common Stock LHDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-39,872
Closed -$482K 6664
2021
Q1
$482K Buy
+39,872
New +$791K ﹤0.01% 5153

Other funds holding LHDX

Goldman Sachs's LHDX Position: Q2 2021 in Review

Goldman Sachs sold out of Lucira Health, Inc. Common Stock (LHDX) in Q2 2021, closing a stake of 39,872 shares — an estimated $482K sold.

Goldman Sachs first reported a position in LHDX in Q1 2021 and held it in 1 quarter. The position peaked at $482K in Q1 2021. 44 funds tracked by Wall St. Rank hold LHDX as of Q2 2021.

  • Goldman Sachs reported no remaining Lucira Health, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Goldman Sachs sold 39,872 Lucira Health, Inc. Common Stock shares in Q2 2021, an estimated $482K.
  • Goldman Sachs first reported a position in Lucira Health, Inc. Common Stock in Q1 2021 and held it in 1 quarter.
  • Goldman Sachs's Lucira Health, Inc. Common Stock position peaked at $482K in Q1 2021.
  • 44 funds tracked by Wall St. Rank held Lucira Health, Inc. Common Stock as of Q2 2021.

Based on Goldman Sachs's 13F filing for Q2 2021, filed 13 Aug 2021.